Theragen Presents New Data at SMISS 2026 Annual Forum Identifying Predictors of Patient Outcomes Following Use of ActaStim®-S Bone Growth Stimulator

ConferenceActaStim®-S Bone Growth StimulatorPositive

AI Analysis

Summary

Theragen presented new data at SMISS 2026 Annual Forum demonstrating how patient demographics, health histories, and surgical techniques may predict recovery outcomes following spinal fusion surgery with ActaStim®-S Bone Growth Stimulator.

Importance:3/10

Sentiment:

0.40

medical devicebone growth stimulatorspinal fusionpatient outcomesconference presentation

Related Companies

$MDCE

Read the original article

Published by PR Newswire Clinical Trials on September 23, 2026 12:00 PM

Read Original